在甲福明治疗前与之后 - - 对类固醇酶活性的影响
Benedikt Gasser1, Genevieve Escher2, Anca-Elena Calin3
1Department of Sport, Exercise and Health, Division Sport and Exercise Medicine, University of Basel, Grosse Allee 6, 4052 Basel, Switzerland.
Life (Basel, Switzerland)
|May 27, 2023
概括
甲福明治疗显著降低类固醇激素度,包括皮质醇代谢物,并抑制3β-HSD活性. 需要进一步的研究才能充分理解它对类固醇激素代谢的复杂影响.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 代谢研究研究 代谢研究
背景情况:
- 以前的研究表明,甲福明会影响类固醇激素水平.
- 这项研究调查了甲治疗影响的特定酶活性.
研究的目的:
- 确定甲胺对类固醇激素度和酶活性的影响.
- 为了比较这些效应在甲福明服药前后.
主要方法:
- 从男性和女性受试者收集的尿液样本,在初次服用甲福林之前和24小时后.
- 用气相色谱-质谱学进行的尿液类固醇分析.
主要成果:
- 甲胺治疗导致类固醇激素代谢产物平均减少35.4%.
- 观察到脱水氨,皮质醇代谢物和18-OH皮质醇的显著下降.
- 在甲福林治疗后检测到抑制3ß-HSD酶活性.
结论:
- 甲福明的使用会影响类固醇激素代谢,影响3β-HSD活性,并可能减少氧化应激.
- 需要进一步的研究来阐明甲胺对类固醇激素通路的影响的完整机制.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
220
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
220
Factors Affecting Drug Biotransformation: Biological
194
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
194
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
299
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
299
Regulation of Metabolism
9.5K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.5K
Hormones Regulating Blood Glucose
3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K


